marzan,
NWBO has been waiting for a flood of good news to come all at once. I believe Linda set up this conference as a starting point for that flood. She has not made a public appearance like this for a long time so we might assume her attorneys have finally given her the all clear or nearly all clear signal. The paper that was being worked on in late Spring should be done, the investigation should be done or nearly done, the Phase 3 should have some type of update since none was given by Dr. Bosch recently and the upcoming trials for L and Direct should have reports with hard evidence indicating real and not imaginary start times. Announcements of collaborations are the types of things presented at a conference and representatives from those collaborators are generally present if the collaboration is in hand. Technical analysis of blinded results might also be explained by an investigator, like the doctor from Kings College, while unblinded results would almost always be expained by a company representative. With a representative from both the Woodford funds and NWBO director Dr. Navid Malik's financial consulting company present the current/future financing implications/opportunities for NWBO might also be zoomed in on as attendees will have immediate access to these folks. A rather interesting scenario from my point of view. Best wishes.
